{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:45:23Z","timestamp":1785753923760,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA022981"],"award-info":[{"award-number":["DA022981"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00213-025-06908-6","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T03:33:55Z","timestamp":1757561635000},"page":"1601-1614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf\/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder"],"prefix":"10.1007","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-1593","authenticated-orcid":false,"given":"William E.","family":"Fantegrossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Fagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamryn","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"5","key":"6908_CR1","first-page":"467","volume":"119","author":"E Abdelnour","year":"2022","unstructured":"Abdelnour E, Jansen MO, Gold JA (2022) Adhd diagnostic trends: increased recognition or overdiagnosis? Mo Med 119(5):467\u2013473","journal-title":"Mo Med"},{"issue":"2","key":"6908_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5455\/medarh.2024.78.159-163","volume":"78","author":"K Al Ghamdi","year":"2024","unstructured":"Al Ghamdi K, AlMusailhi J (2024) Attention-deficit hyperactivity disorder and autism spectrum disorder: towards better diagnosis and management. Med Arch 78(2):159\u2013163. https:\/\/doi.org\/10.5455\/medarh.2024.78.159-163","journal-title":"Med Arch"},{"key":"6908_CR3","doi-asserted-by":"publisher","first-page":"1408876","DOI":"10.3389\/fpsyt.2024.1408876","volume":"15","author":"HA Alsayouf","year":"2024","unstructured":"Alsayouf HA (2024) Growing evidence of pharmacotherapy effectiveness in managing attention-deficit\/hyperactivity disorder in young children with or without autism spectrum disorder: a minireview. Front Psychiatry 15:1408876","journal-title":"Front Psychiatry"},{"key":"6908_CR4","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed). https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"6908_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnsyn.2014.00017","volume":"6","author":"DA Amodeo","year":"2014","unstructured":"Amodeo DA, Yi J, Sweeney JA, Ragozzino ME (2014) Oxotremorine treatment reduces repetitive behaviors in BTBR T\u2009+\u2009tf\/J mice. Front Synaptic Neurosci 6:17","journal-title":"Front Synaptic Neurosci"},{"issue":"3","key":"6908_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/gbb.12343","volume":"16","author":"DA Amodeo","year":"2017","unstructured":"Amodeo DA, Rivera E, Cook EH Jr, Sweeney JA, Ragozzino ME (2017) 5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice. Genes Brain Behav 16(3):342\u2013351","journal-title":"Genes Brain Behav"},{"key":"6908_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2019.02.010","volume":"165","author":"CC Angelakos","year":"2019","unstructured":"Angelakos CC, Tudor JC, Ferri SL, Jongens TA, Abel T (2019) Home-cage hypoactivity in mouse genetic models of autism spectrum disorder. Neurobiol Learn Mem 165:107000","journal-title":"Neurobiol Learn Mem"},{"issue":"10","key":"6908_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1586\/14737175.2013.840417","volume":"13","author":"KM Antshel","year":"2013","unstructured":"Antshel KM, Zhang-James Y, Faraone SV (2013) The comorbidity of ADHD and autism spectrum disorder. Expert Rev Neurother 13(10):1117\u20131128","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"6908_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.110.176271","volume":"337","author":"MH Baumann","year":"2011","unstructured":"Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011) In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther 337(1):218\u2013225","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"6908_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37(5):1192\u20131203","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"6908_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38(4):552\u2013562","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"6908_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbr.2008.09.041","volume":"197","author":"R Benno","year":"2009","unstructured":"Benno R, Smirnova Y, Vera S, Liggett A, Schanz N (2009) Exaggerated responses to stress in the BTBR T + tf\/J mouse: an unusual behavioral phenotype. Behav Brain Res 197(2):462\u2013465","journal-title":"Behav Brain Res"},{"issue":"1","key":"6908_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0022-3565(25)39211-6","volume":"243","author":"M Benuck","year":"1987","unstructured":"Benuck M, Lajtha A, Reith ME (1987) Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243(1):144\u2013149","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"6908_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.33588\/rn.60S01.2014559","volume":"60","author":"C Berenguer-Forner","year":"2015","unstructured":"Berenguer-Forner C, Miranda-Casas A, Pastor-Cerezuela G, Rosell\u00f3-Miranda R (2015) Comorbilidad Del Trastorno Del espectro autista y El d\u00e9ficit de Atenci\u00f3n Con hiperactividad. Estudio de revisi\u00f3n [Comorbidity of autism spectrum disorder and attention deficit with hyperactivity. A review study]. Rev Neurol 60(Suppl 1):37\u201343","journal-title":"Rev Neurol"},{"issue":"2","key":"6908_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1651-2227.2007.00611.x","volume":"97","author":"L Bernfort","year":"2008","unstructured":"Bernfort L, Nordfeldt S, Persson J (2008) Adhd from a socio-economic perspective. Acta Paediatr 97(2):239\u2013245","journal-title":"Acta Paediatr"},{"key":"6908_CR16","unstructured":"Blough B (2008) Dopamine-releasing agents. In: Trudell ML, Izenwasser S (eds) Dopamine transporters: chemistry, biology, and Pharmacology. Wiley, New Jersey, pp 305\u2013320"},{"key":"6908_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbr.2018.03.014","volume":"347","author":"OY Chao","year":"2018","unstructured":"Chao OY, Yunger R, Yang YM (2018) Behavioral assessments of BTBR T\u2009+\u2009Itpr3tf\/J mice by tests of object attention and elevated open platform: implications for an animal model of psychiatric comorbidity in autism. Behav Brain Res 347:140\u2013147","journal-title":"Behav Brain Res"},{"key":"6908_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuroimage.2012.12.029","volume":"70","author":"J Ellegood","year":"2013","unstructured":"Ellegood J, Babineau BA, Henkelman RM, Lerch JP, Crawley JN (2013) Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging. Neuroimage 70:288\u2013300","journal-title":"Neuroimage"},{"issue":"10","key":"6908_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0028-3908(90)90146-I","volume":"29","author":"PJ Elliott","year":"1990","unstructured":"Elliott PJ, Walsh DM, Close SP, Higgins GA, Hayes AG (1990) Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology 29(10):949\u2013956","journal-title":"Neuropharmacology"},{"issue":"1","key":"6908_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(96)12963-3","volume":"215","author":"E Floor","year":"1996","unstructured":"Floor E, Meng L (1996) Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett 215(1):53\u201356","journal-title":"Neurosci Lett"},{"issue":"6","key":"6908_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/cap.2011.0057","volume":"21","author":"TW Frazier","year":"2011","unstructured":"Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL (2011) Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 21(6):571\u2013579","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"6908_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.physbeh.2010.03.005","volume":"100","author":"CA Frye","year":"2010","unstructured":"Frye CA, Llaneza DC (2010) Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiol Behav 100(3):264\u2013267","journal-title":"Physiol Behav"},{"issue":"12","key":"6908_CR23","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","volume":"43","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT (2018) The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology 43(12):2399\u20132407","journal-title":"Neuropsychopharmacology"},{"key":"6908_CR24","first-page":"101","volume":"94","author":"LH Gold","year":"1989","unstructured":"Gold LH, Geyer MA, Koob GF (1989) Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr 94:101\u2013126","journal-title":"NIDA Res Monogr"},{"issue":"2","key":"6908_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2010.07104.x","volume":"116","author":"GG Gould","year":"2011","unstructured":"Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC (2011) Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T\u2009+\u2009tf\/J mouse social behavior. J Neurochem 116(2):291\u2013303","journal-title":"J Neurochem"},{"key":"6908_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.psyneuen.2013.09.003","volume":"39","author":"GG Gould","year":"2014","unstructured":"Gould GG, Burke TF, Osorio MD, Smolik CM, Zhang WQ, Onaivi ES, Gu TT, DeSilva MN, Hensler JG (2014) Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice. Psychoneuroendocrinology 39:158\u2013169","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"6908_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0028-3908(82)90015-6","volume":"21","author":"MG Hadfield","year":"1982","unstructured":"Hadfield MG (1982) Cocaine: peak time of action on isolation-induced fighting. Neuropharmacology 21(7):711\u2013713","journal-title":"Neuropharmacology"},{"issue":"7\u20138","key":"6908_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuropharm.2009.08.020","volume":"57","author":"DJ Heal","year":"2009","unstructured":"Heal DJ, Cheetham SC, Smith SL (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57(7\u20138):608\u2013618","journal-title":"Neuropharmacology"},{"issue":"1","key":"6908_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41398-023-02374-w","volume":"13","author":"V Khachadourian","year":"2023","unstructured":"Khachadourian V, Mahjani B, Sandin S, Kolevzon A, Buxbaum JD, Reichenberg A, Janecka M (2023) Comorbidities in autism spectrum disorder and their etiologies. Transl Psychiatry 13(1):71","journal-title":"Transl Psychiatry"},{"issue":"Pt B","key":"6908_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.nlm.2016.08.001","volume":"134","author":"Y Kosaki","year":"2016","unstructured":"Kosaki Y, Watanabe S (2016) Impaired Pavlovian predictive learning between temporally phasic but not static events in autism-model strain mice. Neurobiol Learn Mem 134(Pt B):304\u201316","journal-title":"Neurobiol Learn Mem"},{"issue":"7","key":"6908_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/10870547231158572","volume":"27","author":"AR Kosheleff","year":"2023","unstructured":"Kosheleff AR, Mason O, Jain R, Koch J, Rubin J (2023) Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment. J Atten Disord 27(7):669\u2013697","journal-title":"J Atten Disord"},{"issue":"3","key":"6908_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","volume":"35","author":"M Langen","year":"2011","unstructured":"Langen M, Kas MJ, Staal WG, van Engeland H, Durston S (2011) The neurobiology of repetitive behavior: of mice\u2026. Neurosci Biobehav Rev 35(3):345\u2013355","journal-title":"Neurosci Biobehav Rev"},{"key":"6908_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00268","volume":"8","author":"Y Leitner","year":"2014","unstructured":"Leitner Y (2014) The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know? Front Hum Neurosci 8:268","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"6908_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/00048679109077746","volume":"25","author":"F Levy","year":"1991","unstructured":"Levy F (1991) The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust N Z J Psychiatry 25(2):277\u2013283","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"6908_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R L\u00f3pez-Arnau","year":"2012","unstructured":"L\u00f3pez-Arnau R, Mart\u00ednez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167(2):407\u2013420","journal-title":"Br J Pharmacol"},{"key":"6908_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.08.020","author":"D Luethi","year":"2018","unstructured":"Luethi D, Kaeser PJ, Brandt SD, Kr\u00e4henb\u00fchl S, Hoener MC, Liechti ME (2018) Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.020","journal-title":"Neuropharmacology"},{"issue":"2","key":"6908_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","volume":"72","author":"MJ Maenner","year":"2023","unstructured":"Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzegerald RT, Furnier SM, Hughes MM, Ladd-Acosta CM, McArthur D, Pas ET, Salinas A, Vehorn A, Wiliams S, Esler A, Grzybowski A, Hall-Lande J, Nguyen RHN, Pierce K, Zahorodny W, Hudson A, Hallas L, Mancilla KC, Patrick M, Shenouda J, Sidwell K, DiRienzo M, Gutierrez J, Spivey MH, Lopez M, Pettygrove S, Schwenk YD, Washington A, Shaw KA (2023) Prevalence and characteristics of autism spectrum disorder among children aged 8 years - Autism and developmental disabilities monitoring network, 11 sites, united states, 2020. MMWR Surveill Summ 72(2):1\u201314","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"6908_CR38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","volume":"33","author":"JA Marusich","year":"2012","unstructured":"Marusich JA, Grant KR, Blough BE, Wiley JL (2012) Effects of synthetic cathinones contained in bath salts on motor behavior and a functional observational battery in mice. Neurotoxicology 33(5):1305\u20131313","journal-title":"Neurotoxicology"},{"key":"6908_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neubiorev.2021.06.001","volume":"128","author":"R Massuti","year":"2021","unstructured":"Massuti R, Moreira-Maia CR, Campani F, S\u00f4nego M, Amaro J, Akutagava-Martins GC, Tessari L, Polanczyk GV, Cortese S, Rohde LA (2021) Assessing undertreatment and overtreatment\/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis. Neurosci Biobehav Rev 128:64\u201373","journal-title":"Neurosci Biobehav Rev"},{"key":"6908_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.112937","volume":"288","author":"SD Mayes","year":"2020","unstructured":"Mayes SD, Waxmonsky JG, Baweja R, Mattison RE, Memon H, Klein M, Hameed U, Waschbusch D (2020) Symptom scores and medication treatment patterns in children with ADHD versus autism. Psychiatry Res 288:112937","journal-title":"Psychiatry Res"},{"issue":"2","key":"6908_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","volume":"7","author":"HG McFarlane","year":"2008","unstructured":"McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN (2008) Autism-like behavioral phenotypes in BTBR T\u2009+\u2009tf\/J mice. Genes Brain Behav 7(2):152\u2013163","journal-title":"Genes Brain Behav"},{"issue":"4","key":"6908_CR42","doi-asserted-by":"publisher","first-page":"e62189","DOI":"10.1371\/journal.pone.0062189","volume":"8","author":"SM McTighe","year":"2013","unstructured":"McTighe SM, Neal SJ, Lin Q, Hughes ZA, Smith DG (2013) The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex. PLoS ONE 8(4):e62189","journal-title":"PLoS ONE"},{"issue":"4","key":"6908_CR43","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/jm050797a","volume":"49","author":"PC Meltzer","year":"2006","unstructured":"Meltzer PC, Butler D, Deschamps JR, Madras BK (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49(4):1420\u20131432","journal-title":"J Med Chem"},{"issue":"6","key":"6908_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.euroneuro.2014.01.013","volume":"24","author":"RT Molenhuis","year":"2014","unstructured":"Molenhuis RT, de Visser L, Bruining H, Kas MJH (2014) Enhancing the value of psychiatric mouse models; differential expression of developmental behavioral and cognitive profiles in four inbred strains of mice. Eur Neuropsychopharmacol 24(6):945\u2013954","journal-title":"Eur Neuropsychopharmacol"},{"key":"6908_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173304","volume":"212","author":"RT Molenhuis","year":"2022","unstructured":"Molenhuis RT, Hutten L, Kas MJH (2022) Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T\u2009+\u2009Itpr3tf\/J inbred mice. Pharmacol Biochem Behav 212:173304","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"6908_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","volume":"176","author":"SS Moy","year":"2007","unstructured":"Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR (2007) Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 176(1):4\u201320","journal-title":"Behav Brain Res"},{"issue":"1","key":"6908_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbr.2007.10.029","volume":"188","author":"SS Moy","year":"2008","unstructured":"Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW (2008) Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 188(1):178\u2013194","journal-title":"Behav Brain Res"},{"issue":"1","key":"6908_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1385\/ENDO:29:1:49","volume":"29","author":"DL Nelson","year":"2006","unstructured":"Nelson DL, Gehlert DR (2006) Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29(1):49\u201360","journal-title":"Endocrine"},{"issue":"1","key":"6908_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/157015911795017047","volume":"9","author":"ES Onaivi","year":"2011","unstructured":"Onaivi ES, Benno R, Halpern T, Mehanovic M, Schanz N, Sanders C, Yan X, Ishiguro H, Liu QR, Berzal AL, Viveros MP, Ali SF (2011) Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. Curr Neuropharmacol 9(1):209\u2013214","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"6908_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000478725","volume":"39","author":"D Pav\u0103l","year":"2017","unstructured":"Pav\u0103l D (2017) A dopamine hypothesis of autism spectrum disorder. Dev Neurosci 39(5):355\u2013360","journal-title":"Dev Neurosci"},{"issue":"2","key":"6908_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1601-183X.2010.00659.x","volume":"10","author":"BL Pearson","year":"2011","unstructured":"Pearson BL, Pobbe RLH, Defensor EB, Oasay L, Bolivar VJ, Blanchard DC, Blanchard RJ (2011) Motor and cognitive stereotypies in the BTBR T\u2009+\u2009tf\/J mouse model of autism. Genes Brain Behav 10(2):228\u2013235","journal-title":"Genes Brain Behav"},{"issue":"11","key":"6908_CR52","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","volume":"62","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62(11):1266\u20131274","journal-title":"Arch Gen Psychiatry"},{"issue":"13","key":"6908_CR53","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1111\/bph.13128","volume":"172","author":"A Rickli","year":"2015","unstructured":"Rickli A, Kopf S, Hoener MC, Liechti ME (2015) Pharmacological profile of novel psychoactive benzofurans. Br J Pharmacol 172(13):3412\u20133425","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"6908_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479(1\u20133):23\u201340","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"6908_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0005-2728(93)90109-S","volume":"1144","author":"G Rudnick","year":"1993","unstructured":"Rudnick G, Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144(3):249\u2013263","journal-title":"Biochim Biophys Acta"},{"key":"6908_CR56","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1038\/tp.2013.16","volume":"3","author":"JJ Schwartzer","year":"2013","unstructured":"Schwartzer JJ, Careaga M, Onore CE, Rushakoff JA, Berman RF, Ashwood P (2013) Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry 3:e240","journal-title":"Transl Psychiatry"},{"key":"6908_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","volume":"190","author":"SR Sharma","year":"2018","unstructured":"Sharma SR, Gonda X, Tarazi FI (2018) Autism spectrum disorder: classification, diagnosis and therapy. Pharmacol Ther 190:91\u2013104","journal-title":"Pharmacol Ther"},{"issue":"2","key":"6908_CR58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","volume":"179","author":"MH Sibley","year":"2022","unstructured":"Sibley MH, Arnold LE, Swanson JM, Hechtman LT, Kennedy TM, Owens E, Molina BSG, Jensen PS, Hinshaw SP, Roy A, Chronis-Tuscano A, Newcorn JH, Rohde LA (2022) Variable patterns of remission from ADHD in the multimodal treatment study of ADHD. Am J Psychiatry 179(2):142\u2013151","journal-title":"Am J Psychiatry"},{"issue":"4","key":"6908_CR59","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.neuroscience.2010.09.059","volume":"171","author":"JL Silverman","year":"2010","unstructured":"Silverman JL, Yang M, Turner SM, Katz AM, Bell DB, Koenig JI, Crawley JN (2010) Low stress reactivity and neuroendocrine factors in the BTBR T\u2009+\u2009tf\/J mouse model of autism. Neuroscience 171(4):1197\u20131208","journal-title":"Neuroscience"},{"key":"6908_CR60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neuropharm.2012.07.042","volume":"68","author":"JL Silverman","year":"2013","unstructured":"Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN (2013) Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology 68:210\u2013222","journal-title":"Neuropharmacology"},{"issue":"1","key":"6908_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/157015911795017425","volume":"9","author":"C Sogawa","year":"2011","unstructured":"Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora I, Kitayama S (2011) Methylone and monoamine transporters: correlation with toxicity. Curr Neuropharmacol 9(1):58\u201362","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"6908_CR62","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1016\/j.ridd.2013.07.028","volume":"34","author":"L Sprenger","year":"2013","unstructured":"Sprenger L, B\u00fchler E, Poustka L, Bach C, Heinzel-Gutenbrunner M, Kamp-Becker I, Bachmann C (2013) Impact of ADHD symptoms on autism spectrum disorder symptom severity. Res Dev Disabil 34(10):3545\u20133552","journal-title":"Res Dev Disabil"},{"issue":"8","key":"6908_CR63","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1038\/tp.2014.69","volume":"4","author":"M Squillace","year":"2014","unstructured":"Squillace M, Dodero L, Federici M, Migliarini S, Errico F, Napolitano F, Krashia P, Di Maio A, Galbusera A, Bifone A, Scattoni ML, Pasqualetti M, Mercuri NB, Usiello A, Gozzi A (2014) Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. Transl Psychiatry 4(8):e427","journal-title":"Transl Psychiatry"},{"issue":"1","key":"6908_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2040-2392-2-7","volume":"2","author":"DT Stephenson","year":"2011","unstructured":"Stephenson DT, O\u2019Neill SM, Narayan S, Tiwari A, Arnold E, Samaroo HD, Du F, Ring RH, Campbell B, Pletcher M, Vaidya VA, Morton D (2011) Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Mol Autism 2(1):7","journal-title":"Mol Autism"},{"issue":"1","key":"6908_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/104454604773840481","volume":"14","author":"KA Stigler","year":"2004","unstructured":"Stigler KA, Desmond LA, Posey DJ, Wiegand RE, McDougle CJ (2004) A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14(1):49\u201356","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"6908_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.rasd.2024.102526","volume":"119","author":"MP Viscomi","year":"2025","unstructured":"Viscomi MP, Czyrska J, Winiarczyk D, Zietek MM, Sampino S (2025) The BTBRT\u2009+\u2009Itpr3tf\/J mouse strain as a model to study the genetic, immune, and metabolic origins of neurodevelopmental disorders. Res Autism Spectr Disord 119:102526","journal-title":"Res Autism Spectr Disord"},{"key":"6908_CR67","first-page":"533","volume":"4","author":"J Volpi-Abadie","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD (2013) Serotonin syndrome. Ochsner J 4:533\u2013540","journal-title":"Ochsner J"},{"issue":"1","key":"6908_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0006-8993(03)02354-0","volume":"971","author":"D Wahlsten","year":"2003","unstructured":"Wahlsten D, Metten P, Crabbe JC (2003) Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T\/+ tf\/tf has severely reduced hippocampal commissure and absent corpus callosum. Brain Res 971(1):47\u201354","journal-title":"Brain Res"},{"key":"6908_CR69","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1460-9568.2009.06714.x","volume":"29","author":"M Yang","year":"2009","unstructured":"Yang M, Clarke AM, Crawley JN (2009) Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability. Eur J Neurosci 29:1663\u20131677","journal-title":"Eur J Neurosci"},{"issue":"2","key":"6908_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12666","volume":"20","author":"J Zhu","year":"2021","unstructured":"Zhu J, Beechinor RJ, Thompson T, Schorzman AN, Zamboni W, Crona DJ, Weiner DL, Tarantino LM (2021) Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains. Genes Brain Behav 20(2):e12666","journal-title":"Genes Brain Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06908-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:02:54Z","timestamp":1785751374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06908-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6908"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06908-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the UAMS Institutional Animal Care and Use Committee. The UAMS animal facility is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International), and procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies, 2011).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read, edited, and approved the final version of the manuscript.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HK is an employee of PharmAla Biotech, Inc. HES and WEF receive salary support and research funding from PharmAla Biotech, Inc. All remaining authors declare no relevant conflicts of interest for these studies.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}